×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Dr Caroline Bouche, Dr Jean- Marc Classe & Dr Jean-Sébastien Frénel

Intervenants :
Dr Jean-Sébastien Frénel,
Pr Emmanuel Barranger, Centre Antoine Lacassagne, Nice
Pr Roman Rouzier, Institut Curie, Paris
Dr Jean-Marc Classe, Institut de cancerologie de l'ouest, Nantes

Cas n°1 : Cancer du sein Triple négatif apparemment accessible à une chirurgie première…. Est-ce toujours une bonne idée ?
Dr Jean-Sébastien Frénel
 
Cas n°2 : Cancer du sein T1 RH+/HER2- : quelle indication de chirurgie axillaire en fonction du statut N clinique ?
Pr Emmanuel Barranger
 
Cas n°3 : Cancer du sein RH+/ HER2neg de 4 cm : comment pondérer l’indication de traitement systémique ? Place d’une signature génomique.
Pr Roman Rouzier
 
Cas n°4 : Patiente initialement N0, traitée par CNA : quelle chirurgie axillaire après la CNA ?
Dr Jean-Marc Classe
 

 

 
Shooting date : 2024-05-22
Last update : 2024-06-05

Suggestions

Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 21st 2021 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, December 21st 2021 from 08am to 09:30am (GMT+1)
New York : Tuesday, December 21st 2021 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, December 21st 2021 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, December 21st 2021 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, December 21st 2021 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 21st 2021 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, December 21st 2021 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, December 22nd 2021 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, December 22nd 2021 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, December 22nd 2021 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, December 22nd 2021 from 04am to 05:30am (GMT+1)

Indication de chimiothérapie néoadjuvante dans la prise en charge des patientes atteintes d’un c...

Share
Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, May 10th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Wednesday, May 10th 2023 from 09am to 10:30am (GMT+2)
New York : Wednesday, May 10th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Wednesday, May 10th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Wednesday, May 10th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Wednesday, May 10th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Wednesday, May 10th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Wednesday, May 10th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Wednesday, May 10th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Thursday, May 11th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Thursday, May 11th 2023 from 01am to 02:30am (GMT+2)
Sydney : Thursday, May 11th 2023 from 03am to 04:30am (GMT+2)
Wellington : Thursday, May 11th 2023 from 05am to 06:30am (GMT+2)

Cancer du sein : actualités et essais en cours, vers où allons-nous ?

Share
Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Thursday, May 25th 2023 from 06:30am to 08am (GMT+2)
San Francisco : Thursday, May 25th 2023 from 09:30am to 11am (GMT+2)
New York : Thursday, May 25th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Thursday, May 25th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Thursday, May 25th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Thursday, May 25th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Thursday, May 25th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, May 25th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Thursday, May 25th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Friday, May 26th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Friday, May 26th 2023 from 01:30am to 03am (GMT+2)
Sydney : Friday, May 26th 2023 from 03:30am to 05am (GMT+2)
Wellington : Friday, May 26th 2023 from 05:30am to 07am (GMT+2)

Cancer du sein RH+ : Quelles optimisations thérapeutiques en 2L métastatique ?

Share
Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, March 19th 2024 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, March 19th 2024 from 08am to 09:30am (GMT+1)
New York : Tuesday, March 19th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, March 19th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, March 19th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, March 19th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, March 19th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, March 19th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, March 20th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, March 20th 2024 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, March 20th 2024 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, March 20th 2024 from 04am to 05:30am (GMT+1)

Prise en charge actuelle pour les cancers du sein triples négatifs métastatiques

Les webinars du réseau FEM-NET

Share
Scroll Up